In contrast, tumor cells from mice treated with anti-PD-L1 present with high lipid peroxidation rates, and ferroptosis inhibition via liproxstatin-1 treatment abolished the mouse response to anti-PD-L1 and anti-CTLA combination therapy113. The gene discussed is CD274; the disease is neoplasm.